
Past Event
7 May 2018 - 11 May 2018,
American University of Beirut, Lebanon

Organisers: Hassan Zaraket American University of Beirut, John Wood (NIBSC, UK) , Jackie Katz (CDC, USA), Rebecca Cox (University of Bergen, Norway)
Participants: 74 students from Lebanon and 20 other countries across the Eastern Mediterranean Region, Europe, Latin America, Africa, and South-East Asia
Lars Haaheim Travel scholarship supported 4 students. Wellcome Trust supported four student travel awards. WHO EMRO and SEARO regional offices supported their personnel attendance.
The five day School focused on influenza and MERS-CoV, including epidemiology and transmission dynamics, virology and genetic characterization, diagnostic techniques, prevention and control strategies, vaccination and immune response and pandemic preparedness and management as well as pandemic preparedness simulation exercise, laboratory rotations in influenza virus research techniques. Nine students presented their own research.
The School was accredited European Accreditation Council for Continuing Medical Education (EACCME) providing 31 European CME credits (ECMEC).
Faculty highlights: 21 local, regional, and international leading expert speakers
Social school dinner
Student feedback was overwhelmingly positive with 88% of students** found the talks either “useful” or “extremely useful”. High praise for international faculty and networking opportunities. A highlight was the role-playing exercise described as both was fun and very informative.
| Session/ Theme | Title | Speaker (Affiliation) | |
| Day 1: 7 May 2018 | |||
| Welcome and Introduction to the School and isirv | Hassan Zaraket (American University of Beirut, Lebanon) John Wood (NIBSC, UK – retired) | ||
| Welcome to the American University of Beirut | Mohammad Sayegh (American University of Beirut, Lebanon) | ||
| Introduction of Department of Experimental Pathology, Immunology, and Microbiology | Ghazi Zaatari (American University of Beirut, Lebanon) | ||
| Epidemiology and Ecology | Human influenza, burden of disease | Hassan Zaraket (American University of Beirut, Lebanon) | |
| Influenza in the Eastern Mediterranean region | Mamunur Rahman Malik (Eastern Mediterranean Regional Office, WHO, Egypt) | ||
| SARI surveillance Lebanon | Nada Ghosn (Ministry of Public Health, Lebanon) | ||
| Outpatient influenza surveillance in Lebanon | Ghassan Dbaibo (American University of Beirut, Lebanon) | ||
| Animal influenza | Isabella Monne (OIE reference laboratory / FAO reference centre for avian influenza and Newcastle disease, Italy) | ||
| Influenza at the human animal interface | Richard Webby (WHO Collaborating Center for Studies on the Ecology of Influenza in Animals and Birds, St Jude Children’s Research Hospital, USA) | ||
| MERS-CoV, influenza and Hajj: burden and challenges | Ziad Memish (Alfaisal University, Ministry of Health, Saudi Arabia; Emory University, USA) | ||
| MERS-CoV surveillance and ecology | Ziad Memish (Alfaisal University, Ministry of Health, KSA; Emory University, USA) | ||
| Virology | Influenza virus structure, replication, and pathogenesis | Maria Zambon (Public Health England, UK) | |
| MERS-CoV structure, replication, and pathogenesis | Stanley Perlman (University of Iowa, USA) | ||
| Day 2: 8 May 2018 | |||
| Diagnosis and Analysis tools | Genetic databases and analysis tools (NCBI and GISAID) | Isabella Monne (OIE reference laboratory / FAO reference centre for avian influenza and Newcastle disease, Italy) | |
| Influenza and MERS-CoV Diagnostic tools: current and future perspectives | Maria Zambon (Public Health England, UK) | ||
| Prevention and Control: Vaccines I | Influenza vaccines | John Wood (Formerly NIBSC, UK) | |
| The immune response to influenza infections and immune correlates of protection | Ali Ellebedy (Washington University, USA) | ||
| Influenza vaccine virus selection process | John Wood (Formerly NIBSC, UK) | ||
| Role of host immune responses in protection, in immunopathological disease and in diagnosis in patients and experimentally infected animals with MERS-CoV. | Stanley Perlman (University of Iowa, USA) | ||
| Original antigenic sin and antibody responses to drifted influenza viruses | Joshy Jacob (Emory University, USA) | ||
| Students’ Presentations | |||
| Day 3: 9 May 2018 | |||
| Prevention and Control: Vaccines II | Effectiveness of inactivated influenza vaccines | Ghassan Dbaibo (American University of Beirut, Lebanon) | |
| Vaccines and strategy implementation | George Kassianos (Royal College of General Practitioners, UK) | ||
| Students’ Presentations | |||
| Prevention and Control: Vaccines II | Universal influenza vaccines | Hadi Yassine (Qatar University, Qatar | |
| Influenza vaccine policies and implementation in the EMR | Nada Melhem (American University of Beirut, Lebanon) | ||
| Challenges in the Diagnostics & Prevention Strategies of MERS-CoV | Ziad Memish (Alfaisal University, Ministry of Health, Saudi Arabia; Emory University, USA) | ||
| Regulatory challenges for influenza vaccines | Ralf Wagner (Paul Ehrlich Institute, Germany) | ||
| Therapeutic Strategies | Mechanisms of action and resistance of antivirals | Hassan Zaraket (American University of Beirut, Lebanon) | |
| Effectiveness of live-attenuated influenza vaccines | Alicia Fry (CDC, USA) | ||
| Social event- Beit Ward Restaurant, Rawche | |||
| Therapeutic Strategies II | Harnessing ancient innate immune mediators to combat modern day pathogens | Joshy Jacob (Emory University, USA) | |
| Student presentations | |||
| Treating influenza with neuraminidase inhibitors | Jonathan Van Tam (Deputy Chief Medical Officer, England) | ||
| Update on avian influenza viruses in human and birds in Egypt | Ghazi Kayali (Human Link, Lebanon)
| ||
| Pandemic Preparedness/ Lab Practice | Pandemic preparedness | Chloe Sellwood (NHS, UK) | |
| Pandemic preparedness workshop | Led by Chloe Sellwood (NHS, UK) | ||
| Laboratory practice | Virus isolation in eggs and cells; titration; detection– CIDR lab | ||
| Day 5: 9 May 2018 | |||
| Guest Lectures: Research Workshop | Prevention and Care of Respiratory Virus Infections in Immunocompromised Children
| Miguela Caniza (St Jude Children’s Research Hospital, USA)
| |
| Immunogenicity testing using viral pseudo-types | Hadi Yassine (Qatar University, Qatar | ||
| Broadening vaccine efficacy: harnessing the HA stalk immune response | Ali Ellebedy (Washington University, USA)
| ||
| New avenues for antiviral discovery | Hassan Zaraket (American University of Beirut, Lebanon) | ||
| Keynote Speaker | How to prevent a major disease outbreak –from SARS to MERS | Ab Osterhaus (Research Center for Emerging Infections and Zoonosis, Germany Erasmus University, Netherlands) | |
| Influenza in the past, present and future | Ab Osterhaus (Research Center for Emerging Infections and Zoonosis, Germany, Erasmus University, Netherlands) | ||
| Closing Remarks | |||

sdr


sdr

dav

dav

dav

dav